Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19
FRIDAY, Sept. 16, 2022 (HealthDay News) — Full-dose anticoagulation reduces thrombotic complications in critically ill patients with COVID-19, according to a study published online Aug. 29 in Circulation to coincide with the European Society of Cardi…
Learn MoreFull-Dose Anticoagulation Beneficial for Critically Ill With COVID-19
FRIDAY, Sept. 16, 2022 (HealthDay News) — Full-dose anticoagulation reduces thrombotic complications in critically ill patients with COVID-19, according to a study published online Aug. 29 in Circulation to coincide with the European Society of Cardi…
Learn MoreCOVID Appears to Raise Risk for Alzheimer’s Disease
FRIDAY, Sept. 16, 2022 (HealthDay News) — COVID-19 infection may significantly boost an older person’s risk of developing Alzheimer’s disease, a new, large-scale study suggests.People 65 and older who contracted COVID were nearly 70% more likely over…
Learn MoreCOVID Appears to Raise Risk for Alzheimer’s Disease
FRIDAY, Sept. 16, 2022 (HealthDay News) — COVID-19 infection may significantly boost an older person’s risk of developing Alzheimer’s disease, a new, large-scale study suggests.People 65 and older who contracted COVID were nearly 70% more likely over…
Learn MoreBedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB
FRIDAY, Sept. 16, 2022 (HealthDay News) — For patients with extensively drug-resistant (XDR) tuberculosis, the overall risk-benefit ratio seems to favor patients receiving the bedaquiline-pretomanid-linezolid regimen with linezolid at a dose of 600 m…
Learn MoreFDA Warns Against Overuse of TPOXX Monkeypox Drug
FRIDAY, Sept. 16, 2022 (HealthDay News) — U.S. health officials are advising doctors not to overuse the only antiviral for monkeypox because there is a risk of the virus mutating and rendering the drug useless.TPOXX (tecovirimat) works by targeting j…
Learn MoreWhich Drugs Fight COVID Best? WHO Updates Treatment Guidelines
FRIDAY, Sept. 16, 2022 (HealthDay News) — In updated guidance issued Thursday, the World Health Organization now recommends against using the antibody drugs sotrovimab and casirivimab-imdevimab for patients with COVID-19.This recommendation replaces …
Learn MorePediatric Brain Abscess, Empyema Hospitalizations Peaked in March 2022
THURSDAY, Sept. 15, 2022 (HealthDay News) — Hospitalizations for pediatric brain abscesses, epidural empyemas, and subdural empyemas associated with Streptococcus species peaked in March 2022, consistent with historical trends, according to research…
Learn MoreACIP Recommends PCV15 for Children Younger Than 19 Years
THURSDAY, Sept. 15, 2022 (HealthDay News) — The 15-valent pneumococcal conjugate vaccine (PCV15) can be used for children aged younger than 19 years, according to recommendations issued by the Advisory Committee on Immunization Practices and publish…
Learn MoreWHO Says Pandemic’s End May Be Near
THURSDAY, Sept. 15, 2022 (HealthDay News) — The end of the COVID-19 pandemic is in sight, the leader of the World Health Organization declared Wednesday, with deaths at their lowest level worldwide since the new coronavirus first began to spread in M…
Learn More